149 related articles for article (PubMed ID: 26663937)
21. High daily fraction dose external radiotherapy for T1 glottic carcinoma: treatment results and prognostic factors.
Gultekin M; Ozyar E; Cengiz M; Ozyigit G; Hayran M; Hosal S; Akyol F
Head Neck; 2012 Jul; 34(7):1009-14. PubMed ID: 22052787
[TBL] [Abstract][Full Text] [Related]
22. Study Protocol: Prospective Study of Concurrent Chemoradiotherapy with S-1 and Hypofractionated Radiotherapy for Outpatients with Early Glottic Squamous Cell Carcinomas.
Kimura K; Itoh Y; Okada T; Kubota S; Kawamura M; Nakahara R; Oie Y; Kozai Y; Takase Y; Tsuzuki H; Nishio N; Hiramatsu M; Fujimoto Y; Mizutani T; Hirakawa A; Naganawa S
Asian Pac J Cancer Prev; 2018 May; 19(5):1195-1199. PubMed ID: 29801401
[TBL] [Abstract][Full Text] [Related]
23. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation.
Spector JG; Sessions DG; Chao KS; Haughey BH; Hanson JM; Simpson JR; Perez CA
Head Neck; 1999 Dec; 21(8):707-17. PubMed ID: 10562683
[TBL] [Abstract][Full Text] [Related]
24. Optimized radiotherapy treatment strategy for early glottic carcinoma.
Ono T; Itoh Y; Ishihara S; Kawamura M; Oie Y; Takase Y; Okumura M; Oyoshi H; Nagai N; Naganawa S
Nagoya J Med Sci; 2023 May; 85(2):241-254. PubMed ID: 37346844
[TBL] [Abstract][Full Text] [Related]
25. Radiotherapy with fraction size of 2.25 Gy in T1-2 laryngeal and hypopharyngeal cancer.
Karasawa K; Kunogi H; Hirai T; Hoji H; Hirowatari H; Izawa H; Ito K; Sasai K; Furuya T; Ozawa S; Matsumoto F; Ito S; Oba S
J Radiat Res; 2013 Jul; 54(4):684-9. PubMed ID: 23297315
[TBL] [Abstract][Full Text] [Related]
26. The impact of treatment time and smoking on local control and complications in T1 glottic cancer.
van der Voet JC; Keus RB; Hart AA; Hilgers FJ; Bartelink H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):247-55. PubMed ID: 9788401
[TBL] [Abstract][Full Text] [Related]
27. Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability.
Held T; Franke H; Lang K; Eichkorn T; Regnery S; Weusthof K; Bauer L; Plath K; Dyckhoff G; Plinkert PK; Harrabi SB; Herfarth K; Debus J; Adeberg S
Radiat Oncol; 2022 Dec; 17(1):199. PubMed ID: 36471398
[TBL] [Abstract][Full Text] [Related]
28. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
Garden AS; Morrison WH; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
[TBL] [Abstract][Full Text] [Related]
29. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
30. A multicenter survey of stage T1 glottic cancer treated with radiotherapy delivered in 2.25-Gy fractions in clinical practice: An initial 5-year analysis.
Itoh Y; Kubota S; Kawamura M; Nomoto Y; Murao T; Yamakawa K; Ishihara S; Hirasawa N; Asano A; Yanagawa S; Naganawa S
Nagoya J Med Sci; 2016 Dec; 78(4):399-406. PubMed ID: 28008195
[TBL] [Abstract][Full Text] [Related]
31. Decreased local control following radiation therapy alone in early-stage glottic carcinoma with anterior commissure extension.
Zouhair A; Azria D; Coucke P; Matzinger O; Bron L; Moeckli R; Do HP; Mirimanoff RO; Ozsahin M
Strahlenther Onkol; 2004 Feb; 180(2):84-90. PubMed ID: 14762660
[TBL] [Abstract][Full Text] [Related]
32. Hyperfractionated radiotherapy for re-irradiation of recurrent esophageal cancer.
Takeda K; Matsushita H; Umezawa R; Yamamoto T; Ishikawa Y; Takahashi N; Suzuki Y; Jingu K
Radiat Oncol J; 2021 Dec; 39(4):265-269. PubMed ID: 34986547
[TBL] [Abstract][Full Text] [Related]
33. High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: unusual toxicity and promising early results.
King SC; Acker JC; Kussin PS; Marks LB; Weeks KJ; Leopold KA
Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):593-9. PubMed ID: 8948343
[TBL] [Abstract][Full Text] [Related]
34. Why to start the concomitant boost in accelerated radiotherapy for advanced laryngeal cancer in week 3.
Terhaard CH; Kal HB; Hordijk GJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):62-9. PubMed ID: 15850903
[TBL] [Abstract][Full Text] [Related]
35. Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer.
Arcangeli G; Saracino B; Danesi DT; De Campora E; Giovinazzo G; Cognetti F; Carlini P; Arcangeli S; Mecozzi A
Am J Clin Oncol; 2002 Oct; 25(5):431-7. PubMed ID: 12393978
[TBL] [Abstract][Full Text] [Related]
36. Hyperfractionated accelerated radiotherapy with concomitant integrated boost of 70-75 Gy in 5 weeks for advanced head and neck cancer. A phase I dose escalation study.
Cvek J; Kubes J; Skacelikova E; Otahal B; Kominek P; Halamka M; Feltl D
Strahlenther Onkol; 2012 Aug; 188(8):666-70. PubMed ID: 22648405
[TBL] [Abstract][Full Text] [Related]
37. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
[TBL] [Abstract][Full Text] [Related]
38. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
Werner-Wasik M; Scott CB; Nelson DF; Gaspar LE; Murray KJ; Fischbach JA; Nelson JS; Weinstein AS; Curran WJ
Cancer; 1996 Apr; 77(8):1535-43. PubMed ID: 8608540
[TBL] [Abstract][Full Text] [Related]
39. Hypofractionation vs. conventional radiotherapy fractionation in the conservative treatment of T1 glottic cancer: a prospective cohort study.
Salas-Salas BG; Domínguez-Nuez DJ; Cabrera R; Ferrera-Alayón L; Lloret M; Lara PC
Clin Transl Oncol; 2020 Jan; 22(1):151-157. PubMed ID: 31152306
[TBL] [Abstract][Full Text] [Related]
40. [Accelerated hyperfractionated radiotherapy combined with simultaneous chemotherapy in locally advanced pharyngeal and oral carcinomas].
Stuschke M; Budach V; Dinges S; Jahnke K; Budach W; Heselmann I; Unger A; Stüben G; Sack H
Strahlenther Onkol; 1994 Dec; 170(12):689-99. PubMed ID: 7817270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
